Xeris Biopharma Holdings, Inc. (XERS)
8.565
+0.14
(+1.60%)
USD |
NASDAQ |
Sep 02, 16:00
8.53
-0.04
(-0.41%)
After-Hours: 20:00
Xeris Biopharma Holdings Free Cash Flow : 55.67M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.67M |
| March 31, 2026 | 47.52M |
| December 31, 2025 | 27.93M |
| September 30, 2025 | 9.975M |
| June 30, 2025 | -16.78M |
| March 31, 2025 | -27.43M |
| December 31, 2024 | -37.85M |
| September 30, 2024 | -33.45M |
| June 30, 2024 | -40.01M |
| March 31, 2024 | -44.56M |
| December 31, 2023 | -50.47M |
| September 30, 2023 | -72.88M |
| June 30, 2023 | -75.85M |
| March 31, 2023 | -81.38M |
| December 31, 2022 | -103.42M |
| September 30, 2022 | -116.24M |
| June 30, 2022 | -121.23M |
| March 31, 2022 | -120.64M |
| Date | Value |
|---|---|
| December 31, 2021 | -96.62M |
| September 30, 2021 | -78.64M |
| June 30, 2021 | -72.68M |
| March 31, 2021 | -76.35M |
| December 31, 2020 | -80.94M |
| September 30, 2020 | -99.66M |
| June 30, 2020 | -113.64M |
| March 31, 2020 | -113.07M |
| December 31, 2019 | -105.45M |
| September 30, 2019 | -94.22M |
| June 30, 2019 | -79.96M |
| March 31, 2019 | -71.00M |
| December 31, 2018 | -57.79M |
| September 30, 2018 | -48.54M |
| June 30, 2018 | -37.45M |
| March 31, 2018 | -29.64M |
| December 31, 2017 | -25.36M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Zevra Therapeutics, Inc. | 32.62M |
| Aclaris Therapeutics, Inc. | -61.34M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.263M |
| Cash from Investing (Quarterly) | -0.209M |
| Cash from Financing (Quarterly) | 1.943M |
| Free Cash Flow Per Share (Quarterly) | 0.0466 |
| Free Cash Flow to Equity (Quarterly) | -22.84M |
| Free Cash Flow to Firm (Quarterly) | 15.00M |
| Free Cash Flow Yield | 3.67% |